Angela Casini
Angela Casini
Verified email at cardiff.ac.uk
Title
Cited by
Cited by
Year
Carbonic anhydrase inhibitors
CT Supuran, A Scozzafava, A Casini
Medicinal research reviews 23 (2), 146-189, 2003
1304*2003
Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pH
E Švastová, A Hulı́ková, M Rafajová, M Zat'ovičová, A Gibadulinová, ...
FEBS letters 577 (3), 439-445, 2004
6592004
Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition
A Weber, A Casini, A Heine, D Kuhn, CT Supuran, A Scozzafava, G Klebe
Journal of medicinal chemistry 47 (3), 550-557, 2004
4692004
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
A Bindoli, MP Rigobello, G Scutari, C Gabbiani, A Casini, L Messori
Coordination Chemistry Reviews 253 (11-12), 1692-1707, 2009
4622009
Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents
CT Supuran, A Casini, A Scozzafava
Medicinal Research Reviews 23 (5), 535-558, 2003
4222003
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
S Nobili, E Mini, I Landini, C Gabbiani, A Casini, L Messori
Medicinal research reviews 30 (3), 550-580, 2010
4162010
Organometallic ruthenium-based antitumor compounds with novel modes of action
WH Ang, A Casini, G Sava, PJ Dyson
Journal of Organometallic Chemistry 696 (5), 989-998, 2011
3372011
A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds
B Bertrand, A Casini
Dalton Transactions 43 (11), 4209-4219, 2014
2922014
Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium (II)− arene compounds
A Casini, C Gabbiani, F Sorrentino, MP Rigobello, A Bindoli, TJ Geldbach, ...
Journal of medicinal chemistry 51 (21), 6773-6781, 2008
2842008
Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX
F Abbate, A Casini, T Owa, A Scozzafava, CT Supuran
Bioorganic & medicinal chemistry letters 14 (1), 217-223, 2004
2802004
Gold (III) compounds as anticancer agents: Relevance of gold–protein interactions for their mechanism of action
A Casini, C Hartinger, C Gabbiani, E Mini, PJ Dyson, BK Keppler, ...
Journal of inorganic biochemistry 102 (3), 564-575, 2008
2522008
Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV
A Casini, J Antel, F Abbate, A Scozzafava, S David, H Waldeck, S Schäfer, ...
Bioorganic & medicinal chemistry letters 13 (5), 841-845, 2003
2422003
Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family
J Lehtonen, B Shen, M Vihinen, A Casini, A Scozzafava, CT Supuran, ...
Journal of Biological Chemistry 279 (4), 2719-2727, 2004
2382004
Organometallic ruthenium (II) arene compounds with antiangiogenic activity
P Nowak-Sliwinska, JR van Beijnum, A Casini, AA Nazarov, G Wagnieres, ...
Journal of medicinal chemistry 54 (11), 3895-3902, 2011
2322011
Gold(I) Carbene Complexes Causing Thioredoxin 1 and Thioredoxin 2 Oxidation as Potential Anticancer Agents
E Schuh, C Pflüger, A Citta, A Folda, MP Rigobello, A Bindoli, A Casini, ...
Journal of medicinal chemistry 55 (11), 5518-5528, 2012
1892012
Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold (III) compounds with bipyridyl ligands
A Casini, MA Cinellu, G Minghetti, C Gabbiani, M Coronnello, E Mini, ...
Journal of Medicinal Chemistry 49 (18), 5524-5531, 2006
1852006
Designing of novel carbonic anhydrase inhibitors and activators
CT Supuran, D Vullo, G Manole, A Casini, A Scozzafava
Current Medicinal Chemistry-Cardiovascular & Hematological Agents 2 (1), 49-68, 2004
1772004
Next-generation anticancer metallodrugs
S Komeda, A Casini
Current topics in medicinal chemistry 12 (3), 219-235, 2012
1762012
COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents
CT Supuran, A Casini, A Mastrolorenzo, A Scozzafava
Mini reviews in medicinal chemistry 4 (6), 625-632, 2004
1692004
Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies
G De Simone, A Di Fiore, V Menchise, C Pedone, J Antel, A Casini, ...
Bioorganic & medicinal chemistry letters 15 (9), 2315-2320, 2005
1682005
The system can't perform the operation now. Try again later.
Articles 1–20